Nomura Holdings’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84M Buy
36,000
+16,955
+89% +$2.05M ﹤0.01% 871
2026
Q1
$3.11M Sell
19,045
-11,440
-38% -$1.76M 0.01% 788
2025
Q4
$5.31M Buy
+30,485
New +$5.56M 0.01% 747
2024
Q1
Sell
-11,010
Closed -$341K 1822
2023
Q4
$341K Buy
+11,010
New +$286K ﹤0.01% 1448
2022
Q3
Sell
-2,496
Closed -$52K 1821
2022
Q2
$52K Buy
+2,496
New +$52.3K ﹤0.01% 1486
2021
Q2
Sell
-14,000
Closed -$475K 2167
2021
Q1
$475K Buy
+14,000
New +$535K ﹤0.01% 1377
2020
Q4
Sell
-16,089
Closed -$519K 1581
2020
Q3
$519K Buy
+16,089
New +$462K ﹤0.01% 995
2020
Q1
Sell
-86,313
Closed -$2.06M 1078
2019
Q4
$2.06M Buy
86,313
+11,013
+15% +$224K 0.01% 642
2019
Q3
$1.3M Sell
75,300
-111,100
-60% -$2.15M ﹤0.01% 765
2019
Q2
$4.81M Buy
186,400
+177,500
+1,994% +$4.94M 0.02% 483
2019
Q1
$259K Sell
8,900
-201,100
-96% -$5.21M ﹤0.01% 1002
2018
Q4
$2.75M Hold
210,000
0.01% 633
2018
Q3
$3.3M Buy
+210,000
New +$4.74M 0.01% 609
2014
Q2
Sell
-3,700
Closed -$70K 2880
2014
Q1
$70K Buy
+3,700
New +$70.3K ﹤0.01% 2558

Other funds holding INSM

Nomura Holdings's INSM Position: Q2 2026 in Review

Nomura Holdings increased its Insmed (INSM) stake by 89% in Q2 2026, buying an estimated $2.05M and bringing the position to 36,000 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #871.

Nomura Holdings first reported a position in INSM in Q1 2014 and has held it in 14 quarters since. The position peaked at $5.31M in Q4 2025. 609 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Nomura Holdings held 36,000 shares of Insmed worth $3.84M as of Q2 2026.
  • Nomura Holdings bought 16,955 Insmed shares in Q2 2026, an estimated $2.05M.
  • Insmed made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #871 holding.
  • Nomura Holdings first reported a position in Insmed in Q1 2014 and has held it in 14 quarters since.
  • Nomura Holdings's Insmed position peaked at $5.31M in Q4 2025.
  • 609 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.